Plain-English translation of NCT07077057 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether an artificial intelligence (AI) tool can help doctors spot certain types of heart attacks that are easy to miss on standard readings. The AI analyzes your heart's electrical activity in real time to help clinicians recognize a dangerous type of heart attack called an occluded myocardial infarction — where a blood vessel is completely blocked but doesn't show up on traditional tests. Researchers want to see if this technology can speed up treatment and reduce damage to your heart.
Some heart attacks don't show the typical warning signs that doctors look for on standard heart electrical tests, so patients can be dangerously delayed in getting the treatment they need. This trial exists to find out whether an AI tool can catch these hidden heart attacks earlier and get patients to life-saving treatment faster.
You likely qualify if…
You likely don't qualify if…
You will come to the hospital with heart attack symptoms and receive an electrical heart scan (ECG). You'll be randomly assigned to one of two groups: either your ECG will be interpreted with help from the AI tool, or your doctor will interpret it the standard way. Either way, you'll receive appropriate medical care. The study will then track your treatment timeline, any heart damage measured through blood tests, and your health outcomes for 30 days after your visit.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Switzerland